Medtronic: latest news - GoINPHARMA
Thursday, 18 October 2018 - 19:47

Medtronic

Medtronic acquires Israel-based Mazor Robotics for $1.64bn

  The large medical device producer Medtronic has acquired Israel-based Mazor Robotics for $1.64bn. The deal strengthens Medtronic’s spinal surgery portfolio. The two companies had already been partners since 2016 when they entered the agreement, which entitles Medtronic to be…

Increasing hardship for Teva: Mylan’s generic to Copaxone approved

Teva Pharmaceuticals is experiencing extremely hard times: the FDA today approved for commercialization the generic drug to Copaxone, developed by Mylan. Copaxone is a blockbuster for the treatment of multiple sclerosis, which generated $4.2bn in 2016 ($2bn in H1 2017),…

Medtronic starts marketing artificial pancreas (type -1 diabetes).

Medtronic issued a press release announcing it will launch its “hybrid closed-loop system” artificial pancreas on the US market. The system, named MiniMed 670G, is an insulin pump approved by FDA, which ensures – through a specific algorithm, that basal…

Medtronic considering sale of a business unit ($5bn)

Medtronic Plc, the largest medical-devices company in the world, is reported to be preparing the sale of its business producing and commercializing needles, catheters and similar devices (Medical supplies), including mainly products obtained through the $29bn acquisition of Covidien Plc…

FDA approves Medtronic’s “artificial pancreas”

FDA has approved Medtronic’s MiniMed 670G hybrid closed looped system. This is the first device approved by the US Agency that monitors glucose and allows to deliver the appropriate dose of basal insulin in patients with type-1 diabetes, 14 years…